BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 38035338)

  • 1. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer.
    Van Dingenen L; Segers C; Wouters S; Mysara M; Leys N; Kumar-Singh S; Malhotra-Kumar S; Van Houdt R
    Front Cell Infect Microbiol; 2023; 13():1298264. PubMed ID: 38035338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
    Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
    Front Immunol; 2022; 13():949490. PubMed ID: 36177041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota modulation: a tool for the management of colorectal cancer.
    Wang Y; Li H
    J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and immunotherapy: a role for microbiota composition.
    Pham F; Moinard-Butot F; Coutzac C; Chaput N
    Eur J Cancer; 2021 Sep; 155():145-154. PubMed ID: 34375896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota: a potential target for improved cancer therapy.
    Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota transplantation: Targeting cancer treatment.
    Wu X; Zhang T; Chen X; Ji G; Zhang F
    Cancer Lett; 2019 Jun; 452():144-151. PubMed ID: 30905818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials.
    Park R; Umar S; Kasi A
    Curr Colorectal Cancer Rep; 2020 Aug; 16(4):81-88. PubMed ID: 32607098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer.
    Yuan H; Gui R; Wang Z; Fang F; Zhao H
    Front Immunol; 2023; 14():1128774. PubMed ID: 36798129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 14. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
    McQuade JL; Ologun GO; Arora R; Wargo JA
    Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer.
    Temraz S; Nassar F; Nasr R; Charafeddine M; Mukherji D; Shamseddine A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
    Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
    EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
    Liu Y; Lau HC; Cheng WY; Yu J
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.